BioNTech (BNTX) cash on hand

Cash · fiscal 2025
€14.88B

BioNTech (BNTX) held cash of €14.88B at the end of fiscal 2025 (December 31, 2025). That is 11.4% lower than the €16.78B of fiscal 2024. Figures as of 18 Nov 2026, 06:56 UTC, from Yahoo Finance.

Key facts

Cash, fiscal 2025
€14.88B
Change on fiscal 2024
−11.4%
Highest on record
€16.78Bfiscal 2024
Lowest on record
€14.06Bfiscal 2022
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Amounts are in EUR. Figures, not advice.

BioNTech cash on hand, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was €16.78B in fiscal 2024 and the lowest €14.06B in fiscal 2022.

History · 4 fiscal years

Cash by fiscal year

BioNTech cash on hand, year by year

BioNTech (BNTX) cash on hand by fiscal year
Fiscal yearCashChangeYear ended
2025€14.88B 11.4% down
2024€16.78B 1.4% up
2023€16.55B 17.7% up
2022€14.06B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone.

How to read it

Cash is the cushion that pays for bad years, buybacks and acquisitions; compare it with total debt to see whether the company is a net borrower.

Cash at health care companies of similar size

Cash of BioNTech and comparable companies
CompanyCashFiscal year
Viatris VTRS$1.51B2025
Tenet Healthcare THC$2.88B2025
BioNTech BNTX€14.88B2025
Guardant Health GH$1.20B2025
Alnylam Pharmaceuticals ALNY$2.91B2025
Zimmer Biomet Holdings ZBH$591.90M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on BNTX

BioNTech, figure by figure

BioNTech (BNTX) overview: price, valuation and scorecardAll health care companies by market value

BioNTech cash on hand: questions and answers

How much cash does BioNTech have?

BioNTech (BNTX) held cash of €14.88B at the end of fiscal 2025 (December 31, 2025). That is 11.4% lower than the €16.78B of fiscal 2024.

What are the highest and lowest cash figures on record for BioNTech?

Across the 4 fiscal years on record (2022–2025), the highest was €16.78B in fiscal 2024 and the lowest €14.06B in fiscal 2022.

How is BioNTech's cash calculated?

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “BioNTech (BNTX) cash on hand”, data as of 18 November 2026. https://funkfolio.com/stock/BNTX/cash

Underlying data: Yahoo Finance.